Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Roswell Park Cancer Institute